2Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium fibrosis and rennin-angiotensin-aldosterone system [ J ]. Circulation,1991,83(6) : 1849-1852.
3Die ZJ, Laviades C, Monreal I. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients[J]. Am J Cardiol, 1995,76(13):14-17.
4Weber KT, Sun Y, Tyayi SC, et al. Collagen network of the myocardium : function, structural remodeling and regulatory mechanism[ J ]. J Mol Cell Cardiol, 1994,26(3) :279-292.
5Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertention[ J]. Cardiovasc Res, 1992,26(7) :671-683.
6Matsusaka T, Katori H, Inagami T, et al. Communication between myocytes and fibroblasts in cardiac remodeling in anglotensin chimeria mice [ J ]. J Clin Invest, 1999,103 (10) : 145 1- 1458.
7Pathak M, Sarkar S, Vellaichamy E, et al. Role of myocytes in myocardial collagen production [ J ]. Hypertension, 2001,37 (3) : 833-840.
8Varo N, Iraburu MJ, Varela M, et al. Chronic AT1 Blockade Stimulates Extra cellular Collagen Type I Degradation and Reverses Myocardial Fibrosis in Spontaneously Hypertensive Rats[ J]. Hypertension, 2000, 35(6) : 1197-1220.
9Schorb W, Booz GW, Dostal DE, et al. Angiotensin Ⅱ is mitogenic in neonatal rat cardiac fibroblasts[ J]. Circ Res, 1993,72(6) :1245-1254.
10Brilla CG, Zhou G, Matsubura L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to Angiotensin Ⅱ and angosterone[J] .J Mol Cell Cardiol, 1994,26(7):809-820.
7Chorianopoulos E, Heger T, Lutz M, et al. FGF-induc- ible 14-kDa protein (Fnl4) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK [ J ]. Basic Res Cardiol, 2010, 105(2) :301-313.
8Polavarapu R, Gongora M C, Winkles J A, et al. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear fac- tor-kappa B pathway activafion[J]. J Neurosci, 2005, 25 (44) :10094-10100.
9Dai L, Gu L, Ding L, et al. TWEAK promotes ovarian cancer cell metastasis via NF-KB pathway activation and VEGF expression [ J ]. Cancer Letters, 2009, 283 ( 2 ) : 159-167.
10Winkles J A. The TWEAK-Fnl4 cytokine-receptor axis: discovery, biology and therapeutic targeting[J]. Nat Rev Drug Discov, 2008, 7(5):411-425.
